亚盛医药公布2021年中期业绩:重要品种临床优势突出,对外合作实现重大突破-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.
第12项!亚盛医药FDA孤儿药认定再创新高,MDM2-p53抑制剂APG-115获ODD治疗IIB-IV期黑色素瘤-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.
信达生物与亚盛医药就Olverembatinib中国商业推广、多品种联合临床开发及股权投资达成战略合作-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.
亚盛医药与信达生物达成2 45亿美元战略合作,涉及HQP1351中国商业推广、APG-2575联合临床开发、股权投资等多领域-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.